/ Published in 2010, Publication

No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.

No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.

LeGoff J, Tanton C, Delaugerre C, Weiss HA, Changalucha J, Ross DA, Mugeye K, Belec L, Hayes RJ, Watson-Jones D.
AIDS. 2010 Oct 23;24(16):2595-6. No abstract available.
PMID: 20940537
Related citation

What you can read next

Prevention, Partners, and Power Imbalances: Women’s views on how male partners affected their adherence to vaginal microbicide gels during HIV prevention trials in Africa.
The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens

You must be logged in to post a comment.